Second Affiliated Hospital of Zhengzhou University
16
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
25%
4 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Role: collaborator
The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery: Stage II
Role: collaborator
Multimodal Neurological Monitoring Strategy After Receiving ECPR
Role: collaborator
Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)
Role: collaborator
Duloxetine for PHN
Role: collaborator
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
Role: collaborator
When Heparin Stopped for Anticoagulation During ECMO Decannulation
Role: lead
The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation
Role: collaborator
Sentinel Lymph Node Mapping In Cervical Cancer
Role: collaborator
Sentinel Lymph Node Mapping In Endometrial Cancer
Role: collaborator
Comparison Of External Physical Vibration Lithecbole(EPVL) In Different Time After Retrograde Intrarenal Surgery(RIRS)
Role: lead
Effect of External Counter Pulsation on Ischemic Stroke
Role: collaborator
Effect of External Counter Pulsation on Coronary Artery Disease
Role: collaborator
Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer
Role: collaborator
The Relationship Between Psychological Factors and Bell's Palsy
Role: collaborator
Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy
Role: collaborator
All 16 trials loaded